Skip to main content

IPO Chilli Ratings

IPO Chilli Ratings
Click to understand how it works

Featured

Singapore Institute of Advanced Medicine Holdings Ltd

Singapore Institute of Advanced Medicine Holdings Ltd ("Sam" or the "Company") is offering 114m new shares comprising 4.415m Public Offer Shares and 109.585m Placement Shares at $0.23 each for a listing on Catalist.  The Company aims to raise $26.2m and the majority of the proceeds will be used to repay debt and the balance for working capital. The market cap based on the IPO price is $231.8m and the offer will close on 14 Feb at 12 noon and starts trading on 16 Feb 2024 at 9am.   Principal Business SAM is a healthcare service provider using advanced technology for early and accurate diagnosis to detect and treat cancer, neurodegenerative and cardiovascular diseases.  SAM has strategic collaborations with public and private institutions for research and clinical work.  SAM's goal is to create a comprehensive one-stop ambulatory cancer centre to undertake the challenges to fight cancer and is one of the first to adopt proto beam therapy treatment in Singapore. Fi

Merry Xmas and a Happy New Year


Received a little surprise from Shares Investment for my small contribution of IPO articles. 

Thanks!

I take this opportunity to wish all readers a blessed festive season and a wonderful year ahead. Hope next year will be even better than this year for you and your loved ones. :)

Thanks for the support to Mr. IPO.

Comments

Anonymous said…
Hi Mr IPO.. Happy New Year to you in advance.

FNN is demergering its property business. Care to share what would be a reasonable price of FNN and FCL after the demerger or what is its targer price so I can judge if it is good to sell it. Thks!
Andy said…
Happy New Year to you. Just surfed in via your Starfish SRS blog site. Looking forward to your IPO assessments!